Study on the improvement of liver injury by controlling sinusoidal cells and spleen
Study on the improvement of liver injury by controlling sinusoidal cells and spleen
批准号:
12470257
负责人:
ARII Shigeki
金额:
$9.02万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1). Cold preservation and reperfusion injury of the liverApoptotic change in the liver was studied with Tunel method and electron microscopy in the cold preservation and reperfusion of the rat liver. Consequently, we found that apoptosis was occurred exclusively in the sinusoidal endothelial cells (SECs) with high incidence, leading to the detachment from the sinusoidal wall. This phenomenon was detected markedly in the cold preservation followed by reperfusion, but not in the cold preservation alone. Apoptosis in this experimental model was suppressed by vascular endothelial growth factor (VEGF) which has been well known to function as surviving and proliferative molecule. Furthermore, we showed that SEC of the fatty liver with cold storage was quite fragile and the size of the intra hepatocytic fatty droplet became larger in size as the cold preservation time was longer. These changes in the cold preserved fatty liver appeared to be one of the major causes of non-functioning graft which is frequently occurred in the fatty liver. We demonstrated that hepatocyte growth factor (HGF) ameliorated the impairment of SECs and inhibited enlargement of the fatty droplet. In addition, we showed that expressions of various kinds of the genes were changed during the cold preservation.2) Improvement of the liver cirrhosis by inhibition of activation of hepatic stellate cells. Previously, we reported that Y-27632, inhibitor of P160ROCK which is an effctor molecule of small G protein Rho, suppressed an activation of hepatic stellate cells, and that this compound inhibited the development into the liver cirrhosis in the CCL4-induced liver fibrosis of the rat. In the present study, we showed that Y-27632 ameliorated the already-established liver cirrhosis in the above-mentioned model without apparent side effects. This result may be a promising strategy for the liver cirrhosis.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Murata, S.Arii, et al.: "Inhibitory effect of Y-27632, a ROCK inhibitor, on pregression of rat liver fibrosis in association with inactivation of hepatic stellate cells"J. Hepatology. 35. 474-481 (2001)
T.Murata、S.Arii 等:“ROCK 抑制剂 Y-27632 对与肝星状细胞失活相关的大鼠肝纤维化进展的抑制作用”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Murata, S.Arii et al.: "Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells"J. Hepatology. 35. 474-481 (2001)
T.Murata、S.Arii 等人:“ROCK 抑制剂 Y-27632 对与肝星状细胞失活相关的大鼠肝纤维化进展的抑制作用”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Arii s., Imamura M.: "Physiological role of sinusoidal endothelial cells and Kupffer cells and their inplication in the pathogenesis of liver injury"J. Hep. Bil. Panc. Surg.. 9. 40-48 (2000)
Arii s.,Imamura M.:“肝窦内皮细胞和库普弗细胞的生理作用及其在肝损伤发病机制中的意义”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Moriga, S.Arii et al.: "Protection of vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation"Transplantation. 69. 141-147 (2000)
T.Moriga、S.Arii 等:“血管内皮生长因子对冷藏引起的窦内皮损伤和细胞凋亡的保护”移植。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Arii, M.Imamura et al.: "Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury"J. Hepato-Biliary-Pancreatic Surg.. 9. 40-48 (2000)
S.Arii,M.Imamura 等:“肝窦内皮细胞和 Kupffer 细胞的生理作用及其在肝损伤发病机制中的意义”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Study on the molecular diagnosis of metastasis and recurrence and molecular targeted therapy for intractable hepato-pancreatic cancer
-
批准号:20249061
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.87万
-
财政年份:2008
-
负责人:ARII Shigeki
-
依托单位:
Multidisciplinary research for molecular mechanism of cancer progression and development of diagnostic and therapeutic tool
-
批准号:18209043
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.03万
-
财政年份:2006
-
负责人:ARII Shigeki
-
依托单位:
Development of molecular- targeting therapy and prediction of mode of recurrence by analysis of molecular mechanism of invasion and metastasis of hepatocellular carcinoma
-
批准号:16390375
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2004
-
负责人:ARII Shigeki
-
依托单位:
Order-made medicine for cancer in the viewpoint of angiogenesis
-
批准号:14370379
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.34万
-
财政年份:2002
-
负责人:ARII Shigeki
-
依托单位:
Development of novel gene therapies in the field of liver surgery
-
批准号:09557104
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:1997
-
负责人:ARII Shigeki
-
依托单位:
Pathophysiology of the liver and development of a novel therapeutics based on morphological and functional study on hepatic sinusoidal
-
批准号:08457322
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:1996
-
负责人:ARII Shigeki
-
依托单位:
Implication of hepatic sinusoidal cells in pathophysiology of the liver diseases and development of novel therapeutic strategies
-
批准号:06454383
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.61万
-
财政年份:1994
-
负责人:ARII Shigeki
-
依托单位: